- Home
- APLE vs ALVO Comparison
APLE vs ALVO Comparison
Compare APLE & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APLE | ALVO |
|---|---|---|
| Founded | 2007 | 2013 |
| Country | United States | Luxembourg |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 1.0B |
| IPO Year | 2007 | 2021 |
Fundamental Metrics
Financial Performance| Metric | APLE | ALVO |
|---|---|---|
| Price | $15.66 | $5.32 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $13.00 | $8.00 |
| AVG Volume (30 Days) | ★ 1.7M | 960.0K |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | ★ 7.12% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.40 | N/A |
| Revenue | ★ $1,238,622,000.00 | N/A |
| Revenue This Year | $2.31 | $13.28 |
| Revenue Next Year | $2.35 | $18.63 |
| P/E Ratio | $38.63 | ★ $18.20 |
| Revenue Growth | ★ 18.98 | N/A |
| 52 Week Low | $10.85 | $2.94 |
| 52 Week High | $17.28 | $9.25 |
Technical Indicators
Market Signals| Indicator | APLE | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 39.05 | 59.64 |
| Support Level | $11.54 | $3.10 |
| Resistance Level | $17.21 | $5.45 |
| Average True Range (ATR) | 0.30 | 0.20 |
| MACD | -0.05 | -0.05 |
| Stochastic Oscillator | 18.75 | 34.59 |
Price Performance
Historical ComparisonAbout APLE Apple Hospitality REIT Inc.
Apple Hospitality REIT Inc is a real estate investment trust that invests in income-producing real estate, majorly in the lodging sector, in the United States. It chiefly invests in upscale service hotels. All of the company's hotels operate under the Marriott or Hilton brands. Apple Hospitality has wholly-owned taxable REIT subsidiaries, which lease all of the company's hotels from wholly-owned qualified REIT subsidiaries. These hotels are managed under separate agreements with various hotel management companies that are unaffiliated with Apple Hospitality. The company derives its income from hotel revenue, its sole segment.
About ALVO Alvotech
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.